netFormulary Leicestershire Health Community NHS
Medicines Formulary  
 Formulary Chapter 2: Cardiovascular system - Full Section

02.01 Positive inotropic drugs
02.01.01 Cardiac glycosides
02.02 Diuretics
02.02.01 Thiazides and related diuretics
02.02.02 Loop diuretics
02.02.03 Potassium-sparing diuretics and aldosterone antagonists
Aldosterone antagonists
02.02.04 Potassium-sparing diuretics with other diuretics
02.02.08 Diuretics with potassium
02.03 Anti-arrhythmic drugs
02.03.01 Management of arrhythmias
02.04 Beta-adrenoceptor blocking drugs
02.05 Drugs affecting the renin-angiotensin system and some other antihypertensive drugs
02.05.01 Vasodilator antihypertensive drugs
02.05.02 Centrally acting antihypertensive drugs
02.05.03 Adrenergic neurone blocking drugs
02.05.04 Alpha-adrenoceptor blocking drugs
02.05.05 Drugs affecting the renin-angiotensin system Angiotensin-converting enzyme inhibitors (ACE inhibitors) Angiotensin-II receptor antagonists Renin inhibitors
02.06 Nitrates, calcium-channel blockers, and potassium-channel activators
02.06.01 Nitrates
02.06.02 Calcium-channel blockers
02.06.03 Other anitanginal drugs
02.06.04 Peripheral vasodilators and related drugs
02.07 Sympathomimetics
02.07.01 Inotropic sympathomimetics
02.08 Anticoagulants and protamine
02.08.01 Parenteral anticoagulants
Low molecular weight heparins
02.08.02 Oral anticoagulants
Stroke prevention in AF
Atrial Fibrillation
VTE treatment
02.08.03 Protamine sulphate
02.09 Antiplatelet drugs
02.10 Myocardial infarction and fibrinolysis
02.10.01 Management of myocardial infarction
02.10.02 Fibrinolytic drugs
02.11 Antifibrinolytic drugs and haemostatics
Blood-related products
02.12 Lipid-regulating drugs
Bile acid sequestrants
Nicotinic acid group
Omega-3 fatty acid compounds